┌──────────────────────────────────────────────────────────────┐ RECORD TYPE ......... SUBJECT FILE SUBJECT TYPE ........ ORG FILE OPENED ......... 2026-07-06 00:16 UTC APPEARANCES ......... 3 ANNOTATIONS KNOWN ALIASES ....... 1 └──────────────────────────────────────────────────────────────┘
FDA
ALSO APPEARS AS
- FDA
APPEARS IN THE MARGINS OF
- Paroxetine Prescription Rates for Adolescents (2001-2015)
This dossier investigates the annual prescription numbers for paroxetine to adolescents in the US and other major markets between 2001 and 2015. While a declassified FDA statement from March 2004 advi…
- Medical Guidance on Paroxetine for Adolescents and Study 329 Reference (2001-2015)
Following the 2001 publication of Study 329, an influential clinical trial on the antidepressant paroxetine (Paxil/Seroxat) for adolescent depression, questions arose regarding its efficacy and safety…
- National Drug Code (NDC) Directory Release List Contributions
The National Drug Code (NDC) is a universal product identifier for human drugs in the United States, established by the FDA. The NDC Directory contains a list of all drugs manufactured, prepared, prop…